At a glance

ClinicalIndex Comparison Record

N/ACompleted· 20 enrolled

Drug / intervention

Bariatric surgeryprocedure

Likely dose

Not stated in record

Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02828579

NCT02828579N/ACompleted

Compare CT.gov

The Impact of Bariatric Surgery on Non-alcoholic Fatty Liver Disease

Jagiellonian University·observational·Posted Jul 11, 2016·Updated Sep 12, 2019

In Brief

An observational study evaluating Bariatric surgery for Obesity and NAFLD. Completed, enrolled 20 participants.

Detailed Summary

Up to 300 million people have a BMI over 30kg/m2. Obesity is the cause of many serious diseases, such as type 2 diabetes, hypertension and NAFLD. Bariatric surgery is the only effective method of achieving weight loss in patients with morbid obesity. The aim of the study is to assess the impact of bariatric surgery on non-alcoholic fatty liver disease in patients operated on due to morbid obesity.

Study Details

Study Typeobservational

Allocation--

Masking--

Primary Purpose--

ConditionsObesity, NAFLD

Countries--

Collaborators--

Timeline

N/ACompletedFinished

201520162017201820192020202120222023202420252026

Enrollment StartFeb 2015

Primary CompletionJan 2016

Study CompletionMar 2016

First PostedJul 2016

TodayJul 2026

First PostedJul 11, 2016

Enrollment StartFeb 1, 2015

Primary CompletionJan 1, 2016

Study CompletionMar 1, 2016

TodayJul 2, 2026

Enrollment to primary: 11 monthsPosted 10.0 years ago

Interventions

Bariatric surgeryprocedure

Laparoscopic Sleeve Gastrectomy (LSG) Laparoscopic Roux-en-Y Gastric Bypass (LRYGB)